Streetbeat News

Earnings

REFI

Chicago Atlantic Real (NASDAQ:REFI) is scheduled to release its quarterly earnings report on March 12, 2024. Analysts predict an EPS of $0.51. The company's historical performance shows mixed results with both earnings beats and misses, leading to varied stock price reactions. Shares have increased by 25.54% over the last 52 weeks, indicating a positive outlook from long-term shareholders. Investors will be keenly watching for the earnings outcome and any forward guidance provided.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 6:01 pm

NOTE

FiscalNote Holdings (NYSE:NOTE) is scheduled to release its quarterly earnings report on 2024-03-12, with analysts expecting an EPS of $-0.15. The company's past earnings performance shows a pattern of beating EPS estimates but experiencing a drop in share price the following day. Shares are currently trading at $2.15, up 21.1% over the last 52 weeks. Investors will be keenly watching for the earnings outcome and particularly the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 6:01 pm

CRMD

Cormedix (NASDAQ:CRMD) is scheduled to release its quarterly earnings report on March 12, 2024, with analysts expecting an EPS of $-0.20. Historical data shows that the company's stock price reacts more significantly to guidance than to earnings beats or misses. Last quarter, Cormedix beat the EPS estimate, resulting in a 6.39% increase in its share price. Over the past year, CRMD shares have decreased by 6.13%, indicating potential concern among long-term investors ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 6:01 pm

BTMD

Biote (NASDAQ:BTMD) is scheduled to release its quarterly earnings report on March 12, 2024, with an estimated EPS of $0.08. Historical data shows mixed reactions to past earnings, with significant price changes following the announcements. Shares have risen 16.74% over the last year, trading at $5.64 as of March 08.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 6:01 pm

PWFL

PowerFleet (NASDAQ:PWFL) is scheduled to release its quarterly earnings report on 2024-03-12, with analysts expecting an EPS of $-0.10. The company's past earnings performance shows a mixed track record, with the last quarter missing EPS estimates by $0.04, leading to a 0.48% drop in share price the following day. Over the last year, PWFL shares have decreased by 3.87%, indicating potential concern among long-term shareholders ahead of the earnings announcement. Investors will be keenly watching for both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 6:01 pm

CSBR

Champions Oncology (NASDAQ:CSBR) is expected to report a quarterly earnings per share (EPS) of $-0.15 on March 12, 2024. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for the next quarter. Historically, the company's share price has reacted to both its earnings performance and the guidance provided. Last quarter, CSBR beat the EPS estimate by $0.02, resulting in a 5.42% share price increase the following day. Over the last 52 weeks, CSBR shares have increased by 30.39%, trading at $5.7 as of March 08.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 6:00 pm

ALGS

Aligos Therapeutics (NASDAQ:ALGS) is scheduled to release its quarterly earnings report on March 12, 2024, with analysts expecting an EPS of $-0.27. The company's past earnings performance shows a mix of beats and misses, with the share price reacting accordingly. Shares are currently trading at $0.8401, down 38.98% over the last 52 weeks. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 6:00 pm

CHDN

Four analysts have recently provided their ratings on Churchill Downs (NASDAQ:CHDN), with a consensus leaning towards a somewhat bullish outlook. The average 12-month price target is set at $146.25, slightly down from the previous target. Analyst Jordan Bender from JMP Securities has maintained and raised his price target to $150, while Daniel Politzer from Wells Fargo has set a target of $137. Churchill Downs showcases strong financial performance with significant revenue growth, exceptional net margin, and impressive ROE and ROA, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 6:00 pm

GPS

ROST

URBN

VSCO

Gap Inc (GPS) exceeded analyst estimates in its fiscal fourth quarter, showing signs of recovery with a 1% YoY sales increase to $4.3 billion and a net income of $185 million. Despite challenges, Old Navy and Gap brands showed growth, while Banana Republic and Athleta struggled. Gap anticipates flat sales for the upcoming year, mirroring cautious outlooks from peers like Ross Stores (ROST), Victoria's Secret (VSCO), and Urban Outfitters (URBN). The company aims to further improve its gross margin in fiscal 2024.

Portfolio Pulse from Upwallstreet

March 11, 2024 | 5:59 pm

BMY

Recent options trading trends for Bristol-Myers Squibb (NYSE:BMY) show a bearish sentiment among whales, with 77% of detected trades being bearish. The trading volume and open interest suggest a target price range of $45.0 to $60.0. Notable options activity includes both bullish and bearish positions, with significant trades in puts and calls. Bristol-Myers Squibb, a leader in immuno-oncology, shows a slight stock price increase to $53.93, potentially indicating an overbought condition. The company's next earnings are expected in 45 days.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 5:46 pm